State In Line To Get $25M As Part Of Drug Marketing SettlementMichigan Attorney General says GlaxoSmithKline underpaid the rebates it owed for drugs paid through the state's Medicaid program.
NanoBio, GSK Start Phase 3 Studies Of Cold Sore TreatmentAnn Arbor-based NanoBio Corp. Wednesday announced the initiation of two Phase 3 trials evaluating its drug candidate NB-001 as a topical treatment for cold sores, a step forward in its over-the-counter drug licensing agreement with GlaxoSmithKline Consumer Healthcare
NanoBio Gets Patent On Cold Sore Product
FDA Debates Safety Of Avandia